Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121184
Published online Oct 15, 2026. doi: 10.4251/wjgo.121184
Published online Oct 15, 2026. doi: 10.4251/wjgo.121184
Figure 1
Efficacy evaluation after pulsed radiotherapy and 2 cycles of atezolizumab.
- Citation: Wan XA, Fang MX, Yuan L, Zhang H, Wang D, Liu ZD. Clinical application of a programmed death ligand-1 inhibitor combined with low-dose pulsed radiotherapy in recurrent metastatic hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(10): 121184
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121184.htm
- DOI: https://dx.doi.org/10.4251/wjgo.121184